157 related articles for article (PubMed ID: 35870050)
1. Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.
Miao H; Geng Y; Li Y; Tang S; Feng F; Li W; Li Y; Liu L; Zhang R; Qiu S; Wu Y; Wang Z; Wang Z; Shao Z; Liu K; Zou L; Yang M; Zhao Y; Chen C; Li Z; Zhang D; Peng P; Qiang X; Wu F; He Y; Chen L; Xiang D; Jiang X; Li M; Liu Y; Liu Y
Cell Oncol (Dordr); 2022 Aug; 45(4):689-708. PubMed ID: 35870050
[TBL] [Abstract][Full Text] [Related]
2. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
Niu J; Li Z; Li F
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
[TBL] [Abstract][Full Text] [Related]
5. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
[TBL] [Abstract][Full Text] [Related]
6. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer.
Huang S; Wang H; Chen W; Zhan M; Xu S; Huang X; Lin R; Shen H; Wang J
J Cell Mol Med; 2020 Jan; 24(2):1599-1613. PubMed ID: 31782270
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
[TBL] [Abstract][Full Text] [Related]
9. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
[TBL] [Abstract][Full Text] [Related]
10. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
11. mda-7/IL-24 induces apoptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial apoptotic pathway.
Jia J; Li S; Gong W; Ding J; Fang C; Quan Z
Oncol Rep; 2011 Jan; 25(1):195-201. PubMed ID: 21109977
[TBL] [Abstract][Full Text] [Related]
12. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Buchegger K; Silva R; López J; Ili C; Araya JC; Leal P; Brebi P; Riquelme I; Roa JC
Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962
[TBL] [Abstract][Full Text] [Related]
13. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
[TBL] [Abstract][Full Text] [Related]
14. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
Mohri D; Ijichi H; Miyabayashi K; Takahashi R; Kudo Y; Sasaki T; Asaoka Y; Tanaka Y; Ikenoue T; Tateishi K; Tada M; Isayama H; Koike K
J Gastroenterol; 2016 Jul; 51(7):711-21. PubMed ID: 26614007
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer.
Matsushita S; Onishi H; Nakano K; Nagamatsu I; Imaizumi A; Hattori M; Oda Y; Tanaka M; Katano M
Cancer Sci; 2014 Mar; 105(3):272-80. PubMed ID: 24438533
[TBL] [Abstract][Full Text] [Related]
16. [The role of tissue factor pathway inhibitor-2 gene in gallbladder cancer].
Qin YY; Gong W; Weng MZ; Li JY; Quan ZW
Zhonghua Wai Ke Za Zhi; 2012 Dec; 50(12):1099-103. PubMed ID: 23336488
[TBL] [Abstract][Full Text] [Related]
17. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway.
Jiang X; Li C; Lin B; Hong H; Jiang L; Zhu S; Wang X; Tang N; Li X; She F; Chen Y
Cancer Sci; 2017 Jun; 108(6):1144-1156. PubMed ID: 28295868
[TBL] [Abstract][Full Text] [Related]
18. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
19. Effects of lncRNA MEG3 on proliferation and apoptosis of gallbladder cancer cells through regulating NF-κB signaling pathway.
Bao D; Yuan RX; Zhang Y
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6632-6638. PubMed ID: 32633352
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
Yang L; Gao Q; Wu X; Feng F; Xu K
J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
